PeriphaGen is a biopharmaceutical company focused on peripheral nerve gene therapy and committed to the development of innovative products for difficult-to-treat neurological disorders thereby improving patients' quality of life. We believe that the best way to treat the nervous system diseases is to directly target neurons. Our proprietary Neuronal Therapeutics (NET) platform can express gene constructs in discrete regions of the nervous system following a simple intradermal injection, allowing for unparalleled treatment specificity and substantially reduced systemic adverse effects. Our lead product, PGN-503, is focused on protecting against Chemotherapy Induced Peripheral Neuropathy (CIPN), the leading dose-limiting side effect observed in the majority of antineoplastic drugs. Our pipeline also includes the treatment of chronic pain by NET drugs designed to block multiple pain pathways through the expression of various gene combinations.
View Top Employees from PeriphaGen IncWebsite | http://www.periphagen.com |
Revenue | $3 million |
Employees | 4 (1 on RocketReach) |
Founded | 2012 |
Address | 2100 Wharton Street Suite 701, Pittsburgh, Pennsylvania 15221, US |
Phone | (412) 488-0348 |
Technologies |
JavaScript,
HTML,
Twitter
+7 more
(view full list)
|
Industry | Biotechnology, Pharmaceutical Manufacturing, Business Services General, Pharmaceutical Development, Business Services, Science and Engineering, Neurology, Genetics, Health Care, Clinical Development, Medical Device, Virology, Pharmaceutical, Pain |
Competitors | Genecure LLC, Gloriana Therapeutics Inc |
SIC | SIC Code 87 Companies, SIC Code 873 Companies |
NAICS | NAICS Code 54171 Companies, NAICS Code 5417 Companies, NAICS Code 541 Companies, NAICS Code 541714 Companies, NAICS Code 54 Companies |
Looking for a particular PeriphaGen Inc employee's phone or email?
The PeriphaGen Inc annual revenue was $3 million in 2024.
David Krisky is the President, Chief Medical Officer, Co-Founder of PeriphaGen Inc.
1 people are employed at PeriphaGen Inc.
PeriphaGen Inc is based in Pittsburgh, Pennsylvania.
The NAICS codes for PeriphaGen Inc are [54171, 5417, 541, 541714, 54].
The SIC codes for PeriphaGen Inc are [87, 873].